Internal Medicine, Geriatric Medicine · Milwaukee, WI
NPI
1144310475
Since 2006
Specialty
Internal Medicine, Geriatric Medicine
Code 207RG0300X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
5228 W Fond Du Lac Ave
Milwaukee, WI, 53216
Phone (414) 536-2100
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$393K
7,024 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Kalluru Vijayabhanu prescribed most often to Medicare patients was Atorvastatin Calcium, with 482 prescriptions and refills. In total Kalluru Vijayabhanu wrote 7,024 Medicare prescriptions that cost $393K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 482 | 485 | 49 | $6,272 |
| Furosemide Generic | 336 | 338 | 31 | $2,726 |
| Pantoprazole Sodium Generic | 304 | 306 | 31 | $7,860 |
| Metoprolol Succinate Generic | 289 | 291 | 31 | $4,069 |
| Amlodipine Besylate Generic | 283 | 285 | 35 | $2,315 |
| Gabapentin Generic | 218 | 220 | 24 | $3,312 |
| Potassium Chloride Generic | 211 | 212 | 22 | $3,013 |
| Omeprazole Generic | 187 | 188 | 19 | $1,722 |
| Torsemide Generic | 180 | 181 | 17 | $2,178 |
| Eliquis Apixaban | 180 | 181 | 21 | $68K |
| Tamsulosin Hcl Generic | 173 | 174 | 17 | $3,002 |
| Metformin Hcl Generic | 170 | 171 | 21 | $1,716 |
| Levothyroxine Sodium Generic | 167 | 168 | 18 | $1,655 |
| Losartan Potassium Generic | 165 | 166 | 21 | $1,852 |
| Carvedilol Generic | 153 | 155 | 18 | $2,124 |
Brand drugs: 964 claims; generic drugs: 5,993 claims; opioid claims: 80.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kalluru Vijayabhanu were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.